好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Cross-titration of lacosamide with a sodium channel blocker in patients with partial onset seizures on a stable dose regimen of levetiracetam: safety and efficacy
Epilepsy/Clinical Neurophysiology (EEG)
(-)
240
Authors/Disclosures
Michel Baulac, MD
PRESENTER 		No disclosure on file
William J. Byrnes, MD No disclosure on file
No disclosure on file
No disclosure on file
Elizabeth Webster No disclosure on file
Marc De Backer, MD, FBCPM, MBA No disclosure on file
No disclosure on file
Philip Van Damme The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for QurAlis. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for VectorY. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NRG Therapeutics. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van Damme has received research support from CSL Behring.